DiscoBio News

Therapeutic Innovation Australia (TIA), supports and facilitates researcher and SME access to a diverse range of Australian translational medical research capabilities. One specific mechanism, providing rapid, entry-level access is via a voucher-style scheme – the Pipeline Accelerator. The Pipeline Accelerator 2021-22 provides SMEs and researchers access to one or more facilities associated with TIA, including core facilities like Griffith Discovery Biology. Discovery Biology provides the following services eligible for the TIA scheme: Small molecule high throughput screening and assay development. Please …

Congratulations to Professor Vicky Avery who has won the 2021 GSC Pro Vice-Chancellor Excellence in Research Engagement Award for her significant engagement activities.

Congratulations to Dr Sandra Duffy, awarded the Degree of Doctor of Philosophy on the 21st December 2021. Her thesis was entitled ‘Consequences of in vitro hyperoxia on Plasmodium falciparum tolerance to artemisinin’.

​​An objective of the Pipeline initiative is to facilitate and encourage access by fee-paying third parties to Pipeline member capabilities. TIA has developed a voucher-style researcher access scheme - the Pipeline Accelerator. ​​This round of the Pipeline Accelerator provides SMEs and researchers  access to one or more facilities associated with TIA, including core facilities and HTS centres (see this list of eligible facilities).  ​ ​Funding, via a fixed-value reimbursement to the service provider, is intended to further reduce the cost of access to a specific capability. …

The ARC Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS) strives to build a critical understanding of peptides and proteins in order to unleash the potential of these biomolecules for human benefit. CIPPS has assembled leading researchers, from diverse disciplines to create a sustainable national research centre that will drive new Australian industries and train the next generation of researchers. Prof Avery’s high throughput screening capability will aid CIPPS’ understanding of the function of new peptides and …